Skip to main content
Vineet Laboratories Limited logo

Vineet Laboratories Limited — Investor Relations & Filings

Ticker · VINEETLAB ISIN · INE505Y01010 LEI · 98450053FEE2D64C6147 BSE.NS Manufacturing
Open in API
Filings indexed 278 across all filing types
Latest filing 2021-07-28 Regulatory Filings
Country IN India
Listing BSE.NS VINEETLAB

About Vineet Laboratories Limited

http://vineetlabs.co.in/

Vineet Laboratories Limited specializes in the development and manufacture of Active Pharmaceutical Ingredients (APIs) and API intermediates. The company focuses on producing high-quality chemical compounds through advanced research and development, catering to diverse therapeutic segments including anti-retroviral, anti-diabetic, and anti-hypertensive treatments. Its core operations involve the synthesis of complex molecules and fine chemicals, supported by manufacturing facilities that adhere to rigorous quality management systems. Vineet Laboratories provides custom synthesis and contract manufacturing services, positioning itself as a technical partner for global healthcare organizations. The company emphasizes process optimization and cost-effective production to deliver reliable chemical solutions for large-scale pharmaceutical applications.

Recent filings

Filing Released Lang Actions
Related Party Transactions
Regulatory Filings
2021-07-28 English
Reply to Clarification- Financial results
Regulatory Filings Classification · 95% confidence The document text is extremely short (117 characters) and contains no substantive content, only placeholders for omitted pictures. There is no financial data, no report content, no announcements, or any textual information to classify as a specific report type. Given the lack of content, the document does not fit any specific filing category and defaults to the fallback category for miscellaneous or non-informative filings, which is Regulatory Filings (RNS).
2021-07-22 English
Certificate under SEBI (Depositories and Participants) Regulations, 2018
Regulatory Filings Classification · 95% confidence The document contains only placeholder text indicating omitted pictures and no substantive textual content or financial data. The true document length is only 243 characters, which is extremely short and does not contain any report or announcement details. Given the lack of content, this document cannot be classified as a full report or detailed announcement. It fits best as a Regulatory Filing (RNS) as a fallback category for miscellaneous filings without specific information.
2021-07-15 English
Trading Window
Regulatory Filings Classification · 95% confidence The document text is extremely short (64 characters) and contains no substantive content, only a placeholder for an omitted picture. There is no financial data, no report content, no announcements, or any other information to classify as a specific report type. Given the lack of content, the document cannot be classified as a report or announcement. It fits best as a Regulatory Filing (RNS) by default, as a fallback category for miscellaneous filings with no clear classification.
2021-07-01 English
Financial Result Updates
Regulatory Filings
2021-06-30 English
Board Meeting — Financial Results
Regulatory Filings Classification · 100% confidence The document text is extremely short (74 characters) and contains no substantive content, only placeholders and an intentionally omitted picture. There is no financial data, no report content, no announcements, or any other information to classify as a specific report type. Given the lack of content, the document does not fit any specific filing category and defaults to the fallback category for miscellaneous or non-informative filings, which is Regulatory Filings (RNS).
2021-06-22 English

Browse filings by year

6 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.